Keywords: ceresine, gains, orphan, status, cypros, pharmaceutical, cpc-211

Ceresine gains orphan status

Article | 01 July 1999

Print This

Cypros Pharmaceutical's Ceresine (CPC-211) has been granted orphandrug status by the US Food and Drug Administration for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in